# TENS alleviates CP/CPPS-related inflammation and pain by modulating Kir2.1-dependent macrophage polarization

**Authors:** Ting Hong, Xinyu Liu, Zepai Chi, Guoyuan Liu, Yuanfeng Zhang, Xuanhao Lin, Peixiu Yao, Qingyun Gong, Yonghai Zhang, Xuwei Hong

PMC · DOI: 10.3389/fimmu.2025.1683500 · Frontiers in Immunology · 2026-01-12

## TL;DR

Transcutaneous electrical nerve stimulation (TENS) reduces inflammation and pain in chronic prostatitis by changing macrophage behavior through specific cellular mechanisms.

## Contribution

This study reveals that TENS alleviates CP/CPPS by modulating Kir2.1-dependent macrophage polarization.

## Key findings

- 4 Hz TENS reduced pelvic pain and inflammation in EAP rats.
- TENS induced M1-to-M2 macrophage repolarization associated with Kir2.1 and TRPV2 downregulation.
- Pharmacological modulation of Kir2.1 reversed TENS effects in macrophages.

## Abstract

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) remains a challenging urological condition. This study investigated the therapeutic potential of transcutaneous electrical nerve stimulation (TENS) in experimental autoimmune prostatitis (EAP) and explored its underlying mechanisms.

Prostate tissue samples from 26 benign prostatic hyperplasia (BPH) patients were collected at Shantou Central Hospital and analyzed for M1/M2 macrophage infiltration using immunohistochemistry (IHC). In animal experiments, 24 male Sprague–Dawley rats were divided into control (n = 4), EAP (n = 7), and TENS treatment groups (n = 13; EAP + 1 Hz, n = 3; EAP + 2 Hz, n = 3; EAP + 4 Hz, n = 7). EAP was induced via prostate antigen injections, and TENS (1–4 Hz) was applied. In cell experiments, RAW264.7 macrophages were grouped into control, LPS-stimulated, electrical stimulation (ES)-treated (0.1–0.5 V/cm), and ES + pharmacological intervention (zacopride/probenecid) groups to study repolarization mechanisms.

In BPH tissues, the M1/M2 macrophage ratio positively correlated with inflammation severity. In EAP rats, 4 Hz TENS significantly alleviated pelvic pain, reduced proinflammatory cytokine expression, and reversed histopathological damage. TENS promoted macrophage repolarization toward the M2 phenotype. ES in vitro similarly induced M1-to-M2 repolarization, which was associated with decreased inwardly rectifying K+ channel Kir2.1 (Kir2.1) and Transient receptor potential vanilloid 2 (TRPV2) expression, membrane depolarization, reduced Ca2+ influx, and a shift from NF-κB/STAT1 to STAT6 signaling. Agonists of Kir2.1 TRPV2 reversed these effects.

TENS alleviates CP/CPPS by promoting M1-to-M2 macrophage repolarization, representing a promising therapeutic strategy.

## Linked entities

- **Genes:** KCNJ2 (potassium inwardly rectifying channel subfamily J member 2) [NCBI Gene 3759], TRPV2 (transient receptor potential cation channel subfamily V member 2) [NCBI Gene 51393], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772], STAT6 (signal transducer and activator of transcription 6) [NCBI Gene 6778]
- **Diseases:** chronic prostatitis (MONDO:0022103), benign prostatic hyperplasia (MONDO:0010811)

## Full-text entities

- **Genes:** Stat6 (signal transducer and activator of transcription 6) [NCBI Gene 362896], Trpv2 (transient receptor potential cation channel, subfamily V, member 2) [NCBI Gene 29465] {aka Vrl1}, Kcnj2 (potassium inwardly-rectifying channel, subfamily J, member 2) [NCBI Gene 29712] {aka Kir2.1}, Stat1 (signal transducer and activator of transcription 1) [NCBI Gene 25124] {aka DD6G4-4}
- **Diseases:** pelvic pain (MESH:D017699), urological (MESH:D014570), CP (MESH:D002972), Chronic prostatitis (MESH:D011472), pain (MESH:D010146), BPH (MESH:D011470), inflammation (MESH:D007249)
- **Chemicals:** probenecid (MESH:D011339), CP (-), zacopride (MESH:C055971), LPS (MESH:D008070)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12857300/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12857300/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC12857300/full.md

---
Source: https://tomesphere.com/paper/PMC12857300